Synergetics USA, Inc. (NASDAQ: SURG) announced that the Company will participate in the Roth Capital Partners 23 rd Annual OC Growth Stock Conference on Wednesday, March 16, 2011, at 2:00 p.m. Pacific time. The Conference will be held at The Ritz Carlton in Dana Point, California. Presenting on behalf of the Company at the Roth Conference will be David M. Hable, President and Chief Executive Officer; Pamela G. Boone, Executive Vice President and Chief Financial Officer; and Jason Stroisch, Vice President of International Sales and Marketing.

About Synergetics USA, Inc.

Through continuous improvement and development of our people, our mission is to design, manufacture and market innovative microsurgical devices, capital equipment, accessories and disposables of the highest quality in order to assist and enable surgeons who perform microsurgery around the world to provide a better quality of life for their patients.

Synergetics USA, Inc. (“Synergetics USA” or the “Company”) is a leading supplier of precision microsurgical devices. The Company’s primary focus is on the microsurgical disciplines of ophthalmology and neurosurgery. Our distribution channels include a combination of direct and independent sales organizations and important strategic alliances with market leaders. The Company’s product lines focus upon precision engineered, microsurgical, hand-held instruments and the delivery of various energy modalities for the performance of less invasive microsurgery including: (i) laser energy, (ii) ultrasonic energy, (iii) radio frequency energy for electrosurgery and lesion generation and (iv) visible light energy for illumination, and where applicable, simultaneous infusion (irrigation) of fluids into the operative field. The Company’s website address is http://www.synergeticsusa.com.

Forward-Looking Statements

Some statements in this release may be “forward-looking statements” for the purposes of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks and uncertainties are discussed in Synergetics’ Annual Report on Form 10-K for the year ended July 31, 2010, as updated from time to time in our filings with the Securities and Exchange Commission.

If you liked this article you might like

Synergetics USA (SURG) Stock Soars After Being Acquired by Valeant

Why Synergetics (SURG) Stock Is Lower Today

4 Health Care Stocks Under $10 to Watch

Synergetics USA Inc. Stock Downgraded (SURG)

A Solid Medical Name

A Solid Medical Name